ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994

In Brief; Burkitt, Epstein Will Divide Bristol-Myers Award; “Italian Nobel” Won By Columbia’s Sol Spiegelman

March 26, 1982

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

41 CCOPs Reported For Recompetition

February 23, 1990